Rubnitz, Jeffrey E <br/><br/>
Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies.  [electronic resource] 

 -  Leukemia research  Apr 2004 
 - 349-52 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0145-2126 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2003.08.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Child, Preschool<br/>Cladribine--administration & dosage<br/>Cytarabine--administration & dosage<br/>Female<br/>Humans<br/>Infant<br/>Leukemia, Myeloid--drug therapy<br/>Male<br/>Recurrence<br/>Treatment Outcome